OBJECTIVES: Patients with thoracic aneurysmal disease involving the arch and the descending or thoracoabdominal aorta may require more than one surgical intervention. The results of one-stage repair using a hybrid stent-graft in the frozen elephant trunk manner are presented.
INTRODUCTION
Patients with complex aortic disease may require a number of interventions during their lifetime. Simultaneous involvement of different aortic segments requires sequential approaches with cumulative surgical trauma and interval mortalities [1] , provided a one- [2, 3] or a two-stage strategy is proposed [4] . In multisegmental thoracic aneurysmal disease, arch replacement with distal repair by a hybrid stent-graft enables one-stage treatment with acceptable mortality. Efforts have been made to develop prognostic indices of rupture based on size [5] , aiming at further clarifying the optimal strategy for repair of thoracic aneurysmal disease.
The classical work by Borst et al. [2] established the basis for the treatment of multisegmental disease and has been used worldwide. It is indicated as part of strategies for completion of repair [6] . Some authors [7] [8] [9] [10] [11] modified this surgical principle introducing the concept of the frozen elephant trunk (FET) in which a stent-graft becomes a part of the procedure. Karck et al. [9] and Jakob et al. [11] used integrated stent-grafts. This hybrid approach allows the simultaneous repair of the proximal, arch and descending intrathoracic aorta.
The present study describes the results of one-stage repair in complex multisegmental thoracic aneurysmal disease in patients enrolled in a prospective multicentre registry.
METHODS

Definitions
Complex aneurysmal disease of the aorta is defined as the combined pathology of the aorta from the aortic root, ascending aorta or aortic arch and extending downwards into the descending thoracic or thoracoabdominal aorta (TAAA). This includes atherosclerotic aneurysms and aortic aneurysms developed on previously dissected aortas as well as aortas with prior interventions that have been found to grow over time after an acute condition. Penetrating aortic ulcers and extensive intramural haematomas [12] may also fit in that definition.
International registry and design
The International E-vita Open® Registry (IEOR) was established in 2008 for the evaluation of the FET treatment with the E-vita Open® hybrid prosthesis ( Jotec GmbH, Hechingen, Germany) in complex thoracic aortic disease [13] and Eleven European cardiothoracic surgical centres participate in this IEOR. Online data submission was performed since September 2008 at http://www. uni-due.de/~tch120/index.htlm. The database is designed to differentiate specific pathologies, aortic aneurysm or dissection. Surgeons at referral centres submit their data electronically into the database of IEOR, located at the West German Heart Center Essen, University Hospital Essen, Essen, Germany.
This study is a retrospective analysis of the prospective database of the IEOR with regard to aneurysmal disease. Variables include demographics, clinical history and physical findings, characteristics of aneurysmal disease, preoperative imaging studies, operative management, postoperative morbidity and mortality, follow-up information and aortic imaging. The database was locked for this study on 1 March 2012.
Hybrid stent-graft
The FET combines the antegrade stent-graft deployment and the use of an integrated non-stented fabric graft for proximal grafting and suturing. The characteristics of this hybrid polyester stent-graft prosthesis have already been described by us [13] . The hybrid stent-graft is designed to avoid proximal endoleak.
Operative procedure
No standardized surgical protocol was applied. However, the main surgical principles were similar including a guide wire for stent-graft insertion and bilateral selective antegrade cerebral perfusion. Approaches for arterial return for cardiopulmonary bypass included the right subclavian artery among others. Venous cannnulation was achieved with a large-bore two-stage cannula in the right atrium. A left ventricular vent was mostly placed in the right superior pulmonary vein. Myocardial protection was provided using Bretschneider crystalloid or antegrade/retrograde cold blood cardioplegia according to departmental policies. Hypothermic circulatory arrest (HCA) was set by surface and perfusion cooling and in most cases, at a bladder temperature of 25°C. Selective antegrade bihemispheric perfusion was used and adequate cooling was confirmed by tympanic temperatures 18-22°C. Near-infrared spectroscopy was used for cerebral monitoring, and cerebral perfusion flow and pressure were maintained within 750-1200 cc/min and 55-65 mmHg, respectively.
During HCA, the arch was inspected and proximal aortic tissue excised. The extent of resection was related to the atherosclerotic involvement of the arch and the decision on a separate or island reconstruction left to the discretion of the surgeon according to findings. The integrated stent-graft was anchored to the proximal descending thoracic aortic stump with monofilament sutures mostly reinforced with felt. For reimplantation of the neck vessels, the island or separate graft techniques were used. The resection of the entire arch tissue was defined as total; this occurred when an island of tissue containing the neck vessels was left or when the neck vessels had to be individually reimplanted. When a tissue bridge between the left subclavian artery and the descending aorta was left and in case of isolated distal arch replacement, arch replacement was defined as subtotal. Mortality was defined as any death that occurred during the first 30 postoperative days or if the patient died beyond that mark without discharge.
Follow-up
Patients were followed on a yearly basis. Other than intraoperative transoesophageal echocardiography and predischarge computed tomography (CT), clinical follow-up data and aortic data from CT studies performed every year were electronically loaded into the IEOR.
Data analysis
To demonstrate the E-vita Open® treatment in relation to the extent of aortic disease, the results of aortic treatment are presented for the thoracic aorta (TAA) and TAAA separately. The twosided Fisher's exact test was used for the evaluation of significance (P < 0.05). Postoperatively and during the follow-up, CT examinations were performed for the evaluation of the aneurysm exclusion by the stent-grafted part of the hybrid prosthesis. Categorical and continuous variables are presented as frequencies and mean ± standard deviation (SD), respectively. Kaplan-Meier analysis was used for the presentation of survival and freedom from aortic events during the investigated period. Statistical analysis was performed using the SPSS software package version 18.0 (SPSS, Inc., Chicago, IL, USA).
RESULTS
From January 2005 to March 2012, the data of 358 patients operated on for combined arch and descending aorta disease, dissection or aneurysm, with the E-vita Open® approach, were prospectively entered in the IEOR. Of them, 113 underwent surgery for arch and descending aortic aneurysm and were included in the present study. The mean age was 67 ± 10 years and 67% (73 of 113) were male. Demographics and associated conditions are summarized in Table 1 . The aneurysm (mean diameter 64 ± 14 mm) was confined in the TAA in 79% (90 of 113) and extended into the TAAA in 20% (23 of 113) ( Table 2) .
Twenty-one patients underwent urgent surgery, 4 within 24 h and 17 within 72 h of onset of symptoms; a contained aortic rupture occurred in 7% (8 of 113). Aetiology of aneurysm was atherosclerosis 73% (83 of 113), medial degeneration 4% (5 of 113), Marfan syndrome 1% (1 of 113), inflammatory disease 3% (3 of 113), pseudoaneurysm formation after coarctation repair 3% (3 of 113), proximal endoleak after descending aorta stent-grafting with aneurysmal progression 4% (4 of 113), post-traumatic 3% (3 of 113) and unknown 10% (11 of 113). Thirty-one (27%) patients had previous cardiovascular or abdominal aortic surgery and/or endovascular aortic intervention. Of them, 17 patients had a previous median sternotomy and 3 a left lateral thoracotomy. Combined cardiac disease was observed in 51% (58 of 113) including coronary artery disease (CAD) in 20% (23 of 113), aortic valve regurgitation (AR) in 23% (26 of 113) and combined CAD with AR in 8% (9 of 113).
Surgery with the hybrid stent-graft
As stated, no standardized surgical protocol was applied. However, the main surgical principles were similar including the use of a guide wire for stent-graft insertion (73%, 82 of 113) and the use of bilateral selective cerebral perfusion (95%, 107 of 113) during HCA.
Cardiopulmonary bypass was established via the right subclavian artery in 67% (76 of 113), the ascending aorta in 21% (24 of 113), the femoral artery in 5% (5 of 113) and another artery including the brachiocephalic trunk in 7% (8 of 113).
The mean diameter of the E-vita Open® hybrid graft was 34 ± 4 mm, with a range between 20 and 40 mm. Stent-graft insertion into the target descending aortic region was complicated in 3 cases. Total arch replacement was performed in 84% (95 of 113) and subtotal in 16% (18 of 113). Replacement of the ascending aorta was performed in 66% (75 of 113); the integrated E-vita Open® prosthesis was used in 16% (18 of 113). Combined root, aortic valve and coronary bypass procedure was performed in 37% (42 of 113). Table 3 summarizes the surgical procedures and the required cardiac, cerebral and visceral operative times.
Thirty-day mortality rate was 10% (11 of 113) and in-hospital mortality rate 12% (13 of 113). The incidence of permanent severe complications like stroke (4%, 4 of 113), paraplegia (4%, 5 of 113) and dialysis (2%, 2 of 113) was 10% (11 of 113). The survival rate at 3 years was 78% (Fig. 1) , with an incidence of aortic-related death of 2% (2 of 100).
Aortic aneurysm treatment
In TAA patients, the rate of complete aneurysm exclusion with the E-vita Open® stent-graft at the first postoperative CT scan usually within the first 30 postoperative days was 84% (76 of 90). In 7% (6 of 90), an additional endovascular intervention was performed postoperatively (3%, 3 of 90) or during the follow-up (3%, 3 of 90) for distal stent-graft extension due to a Type Ib endoleak (4%, 4 of 90), exclusion of an additional aneurysm in the distal descending aorta (1%, 1 of 90) and occlusion of the left subclavian artery after subtotal arch replacement and permanent Type II endoleak (1%, 1 of 90). One secondary surgical intervention was documented for closure of a Type II endoleak originated from the left subclavian ) artery after subtotal arch replacement. Within the survivors, the complete exclusion rate of aneurysmal disease according to latest CT was 95% (75 of 79) (Tables 4 and 5) . In TAAA patients, complete exclusion of the descending aortic aneurysm was documented in 57% (13 of 23) postoperatively (TAA vs TAAA, P = 0.008). In 22% (5 of 23), a secondary endovascular intervention followed postoperatively (9%, 2 of 23) or during the follow-up period (13%, 3 of 23). The endovascular procedure was performed for the treatment of Type Ib endoleak in 13% (3 of 23) and exclusion of additional aneurysmal formation distally (9%, 2 of 23). The incidence of a secondary endovascular aortic repair in TAAA compared with TAA patients was significantly increased (P = 0.045). Secondary aortic surgery in the distal aorta was required in 9% (2 of 23) patients; one for axillary-celiac bypass and one due to thromboembolic event in the abdominal aorta.
Among the survivors, complete exclusion of the thoracic aneurysm in the latest CT was observed in 81% (17 of 21).
The freedom from secondary endovascular aortic repair at 3 years was 88% (Fig. 2) and that from open aortic surgery 90% (Fig. 3) . 
DISCUSSION
Complex intrathoracic aneurysmal aortic disease continues to be a surgical challenge. There are two main problems, the decision with regard to appropriate timing for an operation and the most appropriate strategy for repair. No technique is free from complications and there is controversy on the appropriate indications. On the one hand, it is clear, as confirmed by Elefteriades, that size matters [14] . Needless to say that regardless of size, symptomatic aneurysms must be treated in any way with open surgery or endovascular therapy depending on the experience and preference of attending surgeons, as there is currently no Level A or B evidence with regard to superiority as clearly pointed out by the recent expert consensus document [15] . The second problem is the optimal surgical strategy. The success of thoracic aneurysm surgery with acceptably low mortality has been well documented in the past two decades since the earlier report by Svensson et al. [16] . This is a well-taken message nowadays. The elephant trunk technique as described by Borst et al. [2] confirmed the feasibility of a staged repair of extensive polytopic aneurysms by facilitating proximal control of the descending TAA and by decreasing the risk of re-entering complications as described by Crawford et al. [17] . A recent report by Estrera et al. [4] confirmed that this approach resulted in acceptable morbidity and mortality when repairing extensive thoracic aneurysms. These authors recommended a short period or recovery before proceeding with the second stage after the initial proximal repair due to the risk of rupture in the interval between operations. Inherent cumulative mortality could be as high as 23% as reported by Geirsson et al. [18] . In this regard, the experience by Etz et al. [6] with patients who underwent staged repair of thoracic and thoracoabdominal aortic aneurysms using the classical elephant trunk technique confirmed that their low mortality after stage one seems to justify the liberal use of the elephant trunk technique to facilitate future open or endovascular repair of aneurysms in the distal aorta. They also suggested that if a one-step repair is possible, it should be considered the preferred option [6] .
The FET was introduced to facilitate one-stage repair by stabilizing the dangling elephant trunk [19] . Aneurysm exclusion by the stent-graft seems to be primarily curative and allows easier access for distal open or endovascular reintervention. A major concern is to establish the appropriate indication and timing for surgical repair. As the integrated hybrid prosthesis favours the exclusion of the perigraft space leading to thrombosis and eventual shrinkage of an aneurysm [20] , a one-stage repair of the intrathoracic aorta was offered. It is also well known that some patients may require distal aortic repair due to aortic enlargement and despite the use of a hybrid stent-graft [21] . This multicentre study shows that in complex aneurysmal disease, the FET is a reliable technique and can be performed with an acceptable in-hospital mortality of 12%, considering the complexity of such patients. The issue of organ protection cannot be neglected, too.
In this series, the stroke rate of 4% does not seem to differ from those reported by Etz et al. [6] and Di Eusanio et al. [22] , who reported an overall rate of 6% and 4.5% for their entire cohort, respectively; this latter experience included also non-aneurysmal patients. The issue of spinal cord injury is still a matter of concern. Our study confirms a 4% paraplegia rate (5 of 113), an incidence seemingly consistent in the repair of different aortic diseases [23] . The pathophysiology of spinal cord injury in these patients is still not fully understood, although there is growing evidence that it might be related to the length of the stent-graft and the level of implantation below the body of the eighth thoracic vertebra. Our own group found an association between the true and false lumen diameter in the case of aortic dissection and the presence of spinal cord injury [24] . Chronic aortic aneurysms may behave in a similar way, although this is speculative.
The repair of the aneurysmal disease was considered satisfactory as complete exclusion of aneurysmal disease according to latest CT was 95% [25] . TAAA patients, as expected, showed a different behaviour with complete exclusion of the descending aortic aneurysm documented in 57%. In 22%, a secondary endovascular intervention followed with the largest proportion (13%) undergoing intervention during the follow-up. Complete exclusion of the thoracic aneurysm in the latest CT was observed in 81%. This yielded Kaplan-Meier estimates, as shown in Figs 2 and 3, with freedom from secondary endovascular aortic repair and from open aortic surgery at 3 years of 88% and 90%, respectively. As some patients will require distal repair even after a successful primary operation due to the characteristics of the distal aorta, it is not a surprise that some had additional procedures of some kind. This was well addressed by Pichlmaier et al. [21] .
Limitations
There are some limitations of this study. This multicentre study is based on a registry, the IEOR database. Although it is accepted that a registry does not represent any comparison and is not methodologically sound when compared with controlled randomized studies or meta-analyses, it usually defines the 'real world' practice well. Previous publications from our group have provided some information of interest on specific aspects of extended aortic disease [11, 13, 23, 24] . Secondly, no standardized surgical protocol was applied and this might eventually distort the approach to specific patients. However, the main surgical principles were uniform among the participating surgeons, including the use of selective antegrade cerebral perfusion for brain protection.
CONCLUSIONS
In multisegmental thoracic aneurysmal disease, combined arch replacement with distal repair by a hybrid stent-graft enables onestage treatment with acceptable mortality. Aneurysm exclusion by the stent-graft seems to be primarily curative and allows easier access for distal open or endovascular reintervention.
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APPENDIX. CONFERENCE DISCUSSION
Dr S. Numata (Fukui, Japan): The surgical treatment of multisegmental thoracic aortic aneurysm is challenging, and we still have a controversial problem. This paper presented feasibility of the one-stage repair using frozen elephant trunk, and the surgical results showed a 12% hospital mortality, 4% permanent stroke and 4% permanent paraplegia, which is very reasonable for this sick patient cohort. Mid-term results were also illustrated, showing a relatively low rate of secondary intervention of the aorta.
One thing I did notice was the rate of dialysis after surgery, which, at approximately 23%, is relatively higher than other aortic surgery, I think. So the first question is: Is there any relationship between renal failure and the temperature at circulatory arrest or duration of circulatory arrest?
Dr Mestres: Probably not. Although we have not thoroughly investigated that, as you can see, 25 degrees was the highest temperature reported by the groups that initially represented the work of eight centres. I know that changes from place to place. But in this particular study, the highest temperature was 25, meaning that there was a wide range from 18 to 25. So I cannot give you an appropriate answer. Although we believe that that could be an influencing factor, we are not in the position to confirm that for you at the moment. But it's probable, as in many cases of patients who undergo surgery for thoracic aorta and circulatory arrest, that there is an increased risk because there might be some additional issues not necessarily related to the actual core temperature. Dr Mestres: This series is basically dedicated to aneurysms and there were just a handful of them, a very small number, which were chronic dissections in which an aneurysm developed. So there was a small number of dissected patients. But I'm not really sure. From my own personal experience within the group, I've seen that once. But that was not a chronic patient, it was an acute patient. But, of course, the false lumen could play a role, not only in what you say, but also in the pathogenesis of spinal cord injury, as we have shown in one of the papers that was published by Konstantinos Tsagakis some time ago. That could be another possibility.
Dr K. Kallenbach (Heidelberg, Germany): The shorter 13 cm version of the stent prosthesis has been available for approximately a year. Do you know how many of the grafts implanted so far are the shorter version and is there any connections with the rate of paraplegia?
Dr Mestres: This is a good question; we should go back and have a look at that. I don't remember exactly, but there was probably a small fraction of the patients with the shorter version, because I think a list was available sometime late last year. I don't recall exactly, but it's in the database. I don't have this information now, but I can check it for you if you want.
Dr J. Bachet (Abu Dhabi, United Arab Emirates): There is one thing I don't understand. You said that you have 95% thrombosis around the prosthesis in the descending aorta. This is understandable because the elephant trunk is in the descending aorta. But how can you explain that you have 81% thrombosis downstream where there is no prosthesis? I don't exactly understand how this is possible.
Dr Mestres: The point is that these patients were those with distal thoracoabdominal extension and there were some areas of thrombosis. These patients were part of those who have to be followed and they had secondary interventions, open or surgical. But we noticed on CT scan that there was this sort of thrombosis at a given level, which is the level of the distal part of the stent.
Dr Bachet: So to be very clear, the 81% was only in patients who had a secondary intervention?
Dr Mestres: No, but they were in those patients with distal thoracoabdominal extension, and some of them were reoperated for distal repairs. That is what we expected in this particular population.
Dr Bachet: Probably the manuscript will be clearer, because here there is some ambiguity.
Dr C. Etz (Leipzig, Germany): Just a word of caution. We know from extensive experimental experience and from large clinical series that spinal cord perfusion most likely does not change when you sacrifice segmental arteries down to levels like T11, T12. So there is no change and it's probably because of the intercostals that cover up and take over.
Dr Mestres: We are aware, of course, of your fine studies. And it's, of course, a very well-taken message.
